Member:

Many members of our Cancer Rehabilitation Association are coexisting with cancer. Sometimes the pain caused by treatment is greater than the cancer itself. President Xu, our Rehabilitation Association has a "nasopharyngeal carcinoma group" with hundreds of people. They have all undergone radiotherapy and chemotherapy, but some have relapsed and cannot be treated. Is combined immunotherapy suitable for these patients?

Xu Kecheng:

Sorry, as the president, I didn't care about them. We have very few cases of nasopharyngeal carcinoma treated with combined immunotherapy, maybe because I am not a nasopharyngeal carcinoma professional. But combined immunotherapy is broad-spectrum and should be effective for nasopharyngeal carcinoma. In March 2004, we received a 54-year-old Indonesian patient with nasopharyngeal carcinoma and multiple metastases in the neck named MedAli. After our treatment, all the lesions disappeared. But in 2008, the disease relapsed, and multiple lymph node metastases appeared again, and there were brain metastases. The patient had a splitting headache. Multiple treatments were ineffective. I was using combined immunotherapy at the time, so I gave it to him as well. Two months later, his symptoms completely disappeared, and PET-CT showed that metastatic lesions were no longer visible.

After recovery, Ali enjoyed the warmth of his family.

Ali shared his life and death experience at the Indonesian Cancer Treatment Seminar

Member:

Thank you. Members of our nasopharyngeal carcinoma group are looking forward to your words. You often say in our association that we need "happy treatment" and "ABC", which means "effective, simple and cheap". The compound immune system you introduced is like this. Thank you very much.

　 (To be continued)